145 related articles for article (PubMed ID: 16120045)
1. Feverfew: weeding out the root of leukaemia.
Guzman ML; Jordan CT
Expert Opin Biol Ther; 2005 Sep; 5(9):1147-52. PubMed ID: 16120045
[TBL] [Abstract][Full Text] [Related]
2. Parthenolide: from plant shoots to cancer roots.
Ghantous A; Sinjab A; Herceg Z; Darwiche N
Drug Discov Today; 2013 Sep; 18(17-18):894-905. PubMed ID: 23688583
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH
J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435
[TBL] [Abstract][Full Text] [Related]
4. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.
Guzman ML; Rossi RM; Karnischky L; Li X; Peterson DR; Howard DS; Jordan CT
Blood; 2005 Jun; 105(11):4163-9. PubMed ID: 15687234
[TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.
Kwok BH; Koh B; Ndubuisi MI; Elofsson M; Crews CM
Chem Biol; 2001 Aug; 8(8):759-66. PubMed ID: 11514225
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib suppresses acute myelogenous leukaemia stem-like KG-1a cells via NF-κB inhibition and the induction of oxidative stress.
Costa RGA; Oliveira MS; Rodrigues ACBDC; Silva SLR; Dias IRSB; Soares MBP; de Faro Valverde L; Gurgel Rocha CA; Dias RB; Bezerra DP
J Cell Mol Med; 2024 Apr; 28(8):e18333. PubMed ID: 38652192
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content.
Mittra S; Datta A; Singh SK; Singh A
Acta Pharmacol Sin; 2000 Dec; 21(12):1106-14. PubMed ID: 11603284
[TBL] [Abstract][Full Text] [Related]
8. Parthenolide reduces metastasis by inhibition of vimentin expression and induces apoptosis by suppression elongation factor α - 1 expression.
Jafari N; Nazeri S; Enferadi ST
Phytomedicine; 2018 Mar; 41():67-73. PubMed ID: 29519321
[TBL] [Abstract][Full Text] [Related]
9. The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition.
Sahler J; Bernard JJ; Spinelli SL; Blumberg N; Phipps RP
Thromb Res; 2011 May; 127(5):426-34. PubMed ID: 21272923
[TBL] [Abstract][Full Text] [Related]
10. Rapid extraction and high-performance liquid chromatographic determination of parthenolide in feverfew (Tanacetum parthenium).
Zhou JZ; Kou X; Stevenson D
J Agric Food Chem; 1999 Mar; 47(3):1018-22. PubMed ID: 10552409
[TBL] [Abstract][Full Text] [Related]
11. The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.
Dai Y; Guzman ML; Chen S; Wang L; Yeung SK; Pei XY; Dent P; Jordan CT; Grant S
Br J Haematol; 2010 Oct; 151(1):70-83. PubMed ID: 20701602
[TBL] [Abstract][Full Text] [Related]
12. Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.
Mathema VB; Koh YS; Thakuri BC; Sillanpää M
Inflammation; 2012 Apr; 35(2):560-5. PubMed ID: 21603970
[TBL] [Abstract][Full Text] [Related]
13. The natural products parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma.
Gunn EJ; Williams JT; Huynh DT; Iannotti MJ; Han C; Barrios FJ; Kendall S; Glackin CA; Colby DA; Kirshner J
Leuk Lymphoma; 2011 Jun; 52(6):1085-97. PubMed ID: 21417826
[TBL] [Abstract][Full Text] [Related]
14. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.
Guzman ML; Rossi RM; Neelakantan S; Li X; Corbett CA; Hassane DC; Becker MW; Bennett JM; Sullivan E; Lachowicz JL; Vaughan A; Sweeney CJ; Matthews W; Carroll M; Liesveld JL; Crooks PA; Jordan CT
Blood; 2007 Dec; 110(13):4427-35. PubMed ID: 17804695
[TBL] [Abstract][Full Text] [Related]
15. Parthenolide induces apoptosis and cell cycle arrest of human 5637 bladder cancer cells in vitro.
Cheng G; Xie L
Molecules; 2011 Aug; 16(8):6758-68. PubMed ID: 21829151
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
17. Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin.
Cutlan AR; Bonilla LE; Simon JE; Erwin JE
Planta Med; 2000 Oct; 66(7):612-7. PubMed ID: 11105564
[TBL] [Abstract][Full Text] [Related]
18. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines.
Al-Fatlawi AA; Al-Fatlawi AA; Irshad M; Rahisuddin ; Ahmad A
Pharm Biol; 2015 Jan; 53(1):104-9. PubMed ID: 25289524
[TBL] [Abstract][Full Text] [Related]
19. Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
Pei S; Minhajuddin M; D'Alessandro A; Nemkov T; Stevens BM; Adane B; Khan N; Hagen FK; Yadav VK; De S; Ashton JM; Hansen KC; Gutman JA; Pollyea DA; Crooks PA; Smith C; Jordan CT
J Biol Chem; 2016 Oct; 291(42):21984-22000. PubMed ID: 27573247
[TBL] [Abstract][Full Text] [Related]
20. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.
Heptinstall S; Awang DV; Dawson BA; Kindack D; Knight DW; May J
J Pharm Pharmacol; 1992 May; 44(5):391-5. PubMed ID: 1359053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
